Physician

David P Mccann, MD

According to 2025 Medicare claims, David Mccann, MD (NPI: 1669573713) practices ophthalmology in the Missoula, MT market, with the plurality of this provider's patient population coming from Missoula, MT. This provider's primary affiliated billing organization is ROCKY MOUNTAIN EYE CENTER PC (NPI: 1740291350; TIN: 81-0351370) and primary practice location at 59801-6772. Mccann is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mccann's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 901 traditional Medicare patients, billed 5,684 HCPCS/CPT codes, and received $439,458 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,038 prescription claims across 393 beneficiaries totaling $19,644 in drug costs, led by Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha). DME data shows 50 claims. Open Payments data shows 6 records totaling $159. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $192,075 to $439,458. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	442	1,529	$192,075
2016	703	2,685	$351,021
2017	743	3,106	$340,291
2018	796	3,428	$400,844
2019	865	3,748	$427,414
2020	945	5,191	$370,778
2021	946	5,648	$406,659
2022	918	5,240	$409,471
2023	890	5,587	$422,341
2024	901	5,684	$439,458

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	421	1,032	$34,139
2016	389	1,177	$35,489
2017	381	1,274	$47,938
2018	386	1,276	$54,474
2019	329	904	$44,530
2020	358	954	$41,277
2021	372	1,029	$45,283
2022	384	1,044	$33,863
2023	373	1,076	$31,954
2024	393	1,038	$19,644

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	33	33	$2,037
2017	13	13	$645
2018	50	50	$3,417
2019	38	38	$2,597
2020	11	11	$451
2021	19	19	$1,100
2022	40	41	$3,049
2023	36	36	$3,051
2024	37	50	$3,863

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	311	311	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	509	583	$86
92136	Measurement of corneal curvature and depth of eye	229	393	$29
92134	Imaging of retina	258	269	$28
92285	Photography of content of eyes	202	216	$16

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	302	3,938	$3,315
Latanoprost	Latanoprost	260	14,393	$3,312
Timolol Maleate	Timolol Maleate	132	7,650	$1,529
Prednisolone Acetate	Prednisolone Acetate	41	1,564	$1,356
Erythromycin	Erythromycin Base	60	1,563	$763

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	19	20	$2,105
V2020	Frames, purchases	N	18	18	$1,118
V2624	Polishing/resurfacing of ocular prosthesis	N	N/R	12	$640

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$159	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David P. Mccann, MD?

Tedicare shows public-source Medicare data for David P. Mccann, MD (NPI 1669573713), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David P. Mccann, MD have ACO affiliation data?

David P. Mccann, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to David P. Mccann, MD?

David P. Mccann, MD is linked to ROCKY MOUNTAIN EYE CENTER PC (billing NPI 1740291350) in the available physician profile data.

Does David P. Mccann, MD have Open Payments data?

David P. Mccann, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.